Increased EAT volume after anthracycline chemotherapy is associated with a low risk of cardiotoxicity in breast cancer.
Seong Soon KwonBo Da NamMin-Young LeeMin Hyuk LeeJihyoun LeeByoung-Won ParkDuk Won BangSoon Hyo KwonPublished in: Breast cancer research and treatment (2022)
Measurement of EAT during anthracycline-based chemotherapy might help identify subgroups who are vulnerable to chemotherapy-induced cardiotoxicity. Early detection of EAT volume change could enable tailored chemotherapy with cardiotoxicity prevention strategies.